Edition:
United Kingdom

Biocept Inc (BIOC.OQ)

BIOC.OQ on NASDAQ Stock Exchange Capital Market

1.51USD
16 Nov 2018
Change (% chg)

$-0.10 (-6.21%)
Prev Close
$1.61
Open
$1.60
Day's High
$1.71
Day's Low
$1.51
Volume
7,638
Avg. Vol
90,141
52-wk High
$36.00
52-wk Low
$1.46

Chart for

About

Biocept, Inc. is an early commercial-stage molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) and circulating tumor deoxyribonucleic acid (ctDNA), assays utilizing a standard blood sample, or liquid biopsy. The Company's Target-Selector offering is based on an internally... (more)

Overall

Beta: 3.04
Market Cap(Mil.): $39.03
Shares Outstanding(Mil.): 30.25
Dividend: --
Yield (%): --

Financials

  BIOC.OQ Industry Sector
P/E (TTM): -- 32.19 33.59
EPS (TTM): -1.26 -- --
ROI: -328.01 13.77 15.05
ROE: -550.52 16.51 16.62

Earnings vs. Estimates